The package to different regions may differ.
S3123E SC2 Tri – SARS-CoV-2 Multiplex Nucleic Acid Diagnostic Kit
Brief
COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2.
Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.
The SARS-CoV-2 Multiplex Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used for qualitative detection of the ORF1ab,N and E genes of SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum from patients with SARS-CoV-2 infection, suspected cases with SARS-CoV-2 infection and other patients requiring diagnosis or differential diagnosis of SARS-CoV-2 infection.
Performance
- Performance upgrade: ORF 1ab, N, E genes, three targets
- High sensitivity: 200 copies/ml (one-tube fast release technology), 50 copies/ml (advanced magnetic beads method)
- Time saving: the amplification time was 60min, and the extraction time was the shortest 30min
Parameters
| Product features | Parameters |
| Specimen Type | Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum |
| Extraction Platform | One-tube fast release technology Advanced magnetic beads technology |
| Target Genes | ORF 1ab, N, E gene |
| Internal Control | Pseudovirus containing internal control gene fragments |
| PCR Instrument | SLAN-96P, ABI7500, QuantStudio 5, iPonatic S-Q31A&B |
| Sensitivity | 200 copies/mL (Sample Release Reagent ); 50 copies/mL (Nucleic Acid Extraction-Purification Kit ) |
| Spec. | 24T, 48T, 96T, 12-P |
| Qualification | CE |
